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Background  :  The  airway  muscles  from  allergen-sensitized  animals  in  vitro  show  a  heightened  response  to 
histamine,  but  not  to  carbachol.  This  study  investigated  whether  the  airway  responsiveness  to  histamine  in  vivo  is 
comparable  to  that  of  methacholine  in  human  subjects  with  varying  degrees  of  atopy. 
Methods  :  One-hundred-and-sixty-eight  consecutive  adult  asthma  patients  or  volunteers  underwent  bronch-
oprovocation  tests  to  both  histamine  and  methacholine  after  determining  their  blood  eosinophil  counts,  serum  total  IgE 
levels  and  skin  test  reactivity  to  10  common  aeroallergens.
Results  :  The  responsiveness  to  histamine  was  significantly  related  to  that  to  methacholine  (r=0.609,  p<0.001),  but 
many  individuals  with  a  negative  methacholine  test  response  showed  a  positive  response  to  histamine.  The 
histamine-bronchial  reactivity  index  (BRindex)  was  significantly  higher  than  the  methacholine-BRindex  in  subjects  with 
a  positive  response  to  none  (n=69,  p<0.01)  or  only  one  (n=42,  p<0.001)  of  histamine  and  methacholine,  while  there  was 
no  significant  difference  in  the  subjects  with  positive  responses  to  both  of  them  (n=57).  The  histamine-BRindex  was 
significantly  higher  than  the  methacholine-BRindex  in  the  subjects  with  mild  histamine  hyperresponsiveness  (n=58,  1.28
±0.01  vs.  1.20±0.02,  respectively,  p<0.001).  Both  histamine  and  methacholine  responsiveness  was  significantly  related 
to  the  atopy  markers.  However,  the  histamine-BRindex/methacholine-BRindex  ratio  of  the  atopics  was  not  significantly 
different  from  that  of  the  non-atopics. 
Conclusions  :  The  airway  responsiveness  to  histamine  is  comparable  to  that  of  methacholine  in  the  subjects  with 
positive  responses  to  both  histamine  and  methacholine,  but  the  airway  responsiveness  to  histamine  is  greater  than  that 
to  methacholine  in  those  subjects  with  mild  airway  hyperresponsiveness,  regardless  of  atopy. 
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INTRODUCTION
Atopic  allergy,  including  asthma,  is  characterized  not  only  by 
the  enhanced  production  of  allergen-specific  IgE  antibodies,  but 
also  by  increased  sensitivity  of  the  target  organs
1).  Some  people 
can  be  sensitized  to  allergens,  but  not  be  allergic
2),  i.e.,  they 
lack  increased  sensitivity  of  the  target  organs;  however,  many 
individuals  with  respiratory  allergy  have  an  increased  airway 
response  specifically  to  allergens  that  they  are  sensitized  to  or 
they  are  nonspecifically  sensitized  to  various  stimuli  such  as 
histamine  and  methacholine.  Airway  responsiveness  to  histamine 
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diagnosing  asthma
3).
Although  many  patients  with  asthma  have  airway  hyper- 
responsiveness  (AHR)  to  various  pharmacological  or  physical 
bronchoconstricting  stimuli,  it  has  been  recognized  that  they 
often  respond  to  one  stimulus,  but  not  to  all  other  stimuli
4). 
Antonissen  et  al.
5, 6)  demonstrated  a  heightened  response  to 
histamine,  but  not  to  a  cholinergic  agonist,  in  the  airway 
muscles  from  allergen-sensitized  animals.  Histamine  is  the 
typical  mediator  of  the  allergic  response,  and  leukotrienes, 
another  allergic  mediator,  increase  the  number  of  histamine 
receptors
7).  Therefore,  atopic  individuals  might  have  an 
increased  specific  sensitivity  to  an  allergic  mediator.  However, 
Juniper,  et  al.
8)  have  showed  that  the  histamine-AHR  is 
comparable  to  the  methacholine-AHR  in  asthma  patients,  so 
both  tests  are  used  interchangeably  in  general  practice  to 
diagnose  asthma.  This  study  investigated  whether  the  airway 
responsiveness  to  histamine  is  comparable  to  that  of 
methacholine  in  subjects  with  varying  degrees  of  atopy.
MATERIALS AND METHODS
Subjects
One-hundred-and-sixty-eight  consecutive  adult  asthma 
patients  and  healthy  volunteers  whose  ages  were  less  than  50 
years  were  recruited  from  Chonnam  National  University 
Hospital.  The  enrolled  patients  were  mostly  young  adult  men 
who  required  a  medical  certificate  for  asthma  in  order  to  be 
exempted  from  obligatory  military  service,  and  medical  students 
and  hospital  employees,  including  doctors  and  nurses,  were 
also  enrolled.  The  participants  were  classified  as  3  groups, 
based  on  their  responses  to  methacholine  and  histamine 
bronchoprovocation  tests.  Sixty-nine  subjects  had  negative 
responses  to  both  tests  (the  both  negative  group);  42  subjects 
had  a  positive  response  to  one  test  only  (the  sole  positive 
group),  and  the  other  57  subjects  had  positive  responses  to 
both  tests  (the  both  positive  group).  The  Institutional  Review 
Board  of  Chonnam  National  University  Hospital  approved  the 
study.  All  the  patients  were  informed  of  the  experimental 
procedures  and  they  provided  written  informed  consent  for 
participation.
Study  design
On  the  first  day  of  the  study,  baseline  spirometry,  allergy 
skin-prick  tests  and  laboratory  tests  for  the  complete  blood 
counts  and  measuring  the  total  serum  IgE  were  performed  after 
taking  a  history  and  conducting  a  physical  examination.  The 
airway  responsiveness  to  methacholine  or  histamine  (selected 
randomly)  was  then  measured.  The  test  was  performed  again 
the  next  day,  at  the  same  time  of  day,  with  the  other  agent.
Studies  for  atopy  markers
9)
The  total  IgE  levels  were  determined  using  nephelometry 
(normal  <  100  IU/mL;  Behring  Diagnostics  GmbH,  Germany). 
Allergy  skin-prick  tests  were  carried  out  using  ten  common 
aeroallergen  extracts  (Allergopharma,  Reinbek,  Germany):  Derma-
tophagoides  farinae,  D.  pteronyssinus,  cockroach  (Periplaneta 
americana),  cat,  dog,  Aspergillus,  hazel,  birch,  timothy  and 
ragweed;  histamine  (1  mg/mL)  and  saline  (0.9%)  solutions  were 
used  as  the  positive  and  negative  controls,  respectively.  The 
longest  and  perpendicular  diameters  of  each  wheal  were 
measured  using  vernier  calipers  (Absolute  Digimatic;  Mitutoyo, 
Japan)  15  minutes  after  a  prick  with  a  26-gauge  needle,  and 
the  arithmetic  mean  of  the  recorded  measurements  was  used 
as  the  representative  value.  Reactivity  was  graded  according  to 
the  ratio  of  the  size  of  the  allergen-induced  wheal  to  the  size 
of  the  wheal  elicited  by  the  histamine  solution  (the  A/H  ratio), 
and  this  was  categorized  as  follows:  1+:  25-49%,  2+:  50～99%, 
3+:  100～199%,  4+:  ≥200%.  The  sums  of  the  grades  for  the 
ten  allergens  and  for  the  two  house  dust  mite  extracts  were 
defined  as  the  atopy  score  and  the  house  dust  mite  score, 
respectively.  The  skin  test  reactivity  of  ≥3+  was  regarded  as 
indicative  of  a  clinically  significant  positive  response
10),  and  the 
subjects  having  at  least  one  significant  positive  response  were 
deemed  as  atopic. 
Airway  responsiveness
The  bronchial  challenge  tests  were  followed  a  standardized 
tidal  breathing  method
11).  The  forced  expiratory  volume  in  one 
second  (FEV1)  was  measured  in  triplicate  before  the  test  and  in 
duplicate  (at  30  and  90  sec)  after  each  inhalation  period  with 
using  a  spirometer  (Spiro  Analyzer  ST-250,  Fukuda  Sangyo, 
Tokyo,  Japan).  The  selected  predictive  equation  for  FEV1  was 
that  recommended  by  the  Intermountain  Thoracic  Society
12). 
Isotonic  saline,  followed  by  a  methacholine  (Sigma-Aldrich,  St. 
Louis,  MO)  solution  or  a  histamine  (Sigma-Aldrich)  solution,  was 
aerosolized  at  room  temperature  in  a  DeVilbiss  646  nebulizer 
(DeVilbiss,  Somerset,  PA;  output  0.13  mL/min).  In  view  of  the 
chemical  stability  of  methacholine  and  histamine  solutions,  they 
were  prepared  fresh  on  the  morning  of  each  challenge  day.  The 
dilution  increments  used  in  the  first  year  of  this  study  were 
0.075,  0.15,  0.31,  0.62,  1.25,  2.5,  5.0,  10  and  25  mg/mL.  Since 
many  of  the  subjects  could  not  tolerate  the  highest  histamine 
dose,  this  highest  dose  was  then  reduced  from  25  to  16  mg/mL 
in  the  second  year.  The  aerosols  were  inhaled  by  tidal  breathing 
over  a  2  minute  period  at  5-min  intervals,  through  the  mouth 
with  the  nose  clipped.  The  challenge  test  was  discontinued  if 
the  FEV1  dropped  by  20%  or  more  from  the  post-saline  FEV1, 
or  if  the  maximum  concentration  of  agonist  was  administered. 
The  provocation  concentration  of  methacholine  or  histamine 
resulting  in  a  20%  fall  in  the  FEV1  (PC20)  was  calculated  by The  Korean  Journal  of  Internal  Medicine  :  Vol.  22,  No.  3,  September  2007 166
Both  Sole Both
Negative
‡ Positive
‡ Positive
‡ 
(n=69) (n=42)  (n=57) 
Age  (years)  26.9±0.6 26.2±1.0 24.8±0.8 
Gender  (M/F)  48/21 28/14 36/21
Height  (cm) 169.9±0.9 169.8±1.4 169.3±1.1
Blood  eosinophils  >  400/μL6   (8.7%) 3  (7.1%) 9  (15.8%) 
Serum  IgE  >  100  IU/mL
** 32  (46.4%) 17  (40.5%) 42  (73.7%)
Atopy
** 32  (47.1%) 23  (54.8%) 44  (78.6%)
House  dust  mites  SPT
†  (+)
*** 30  (44.1%) 20  (47.6%) 43  (76.8%)
FEV1  (%  predicted) 92.2±2.0 88.5±1.9 87.5±1.5
Histamine  PC20
*** 
    (Geometric  mean,  mg/mL) >16 5.36 1.54
    >  16  mg/mL 69  (100%) 3  (7.1%) 0
    2～16  mg/mL  0   32  (76.2%) 26  (45.6%)
    0.2～2  mg/mL 0   6  (14.3%) 29  (50.9%)
    <  0.2  mg/mL 0 1  (2.4%) 2  (3.5%)
‡negative  or  positive  airway  hyperresponsiveness  {PC20  [provocation  concentration  resulting  in  a  20%  fall  in  forced  expiratory  volume 
in  one  second  (FEV1)]  <16  mg/mL}  to  histamine  and  methacholine; 
†Skin  prick  test; 
**p<0.01  and 
***p<0.001. 
Table  1.  Clinical  characteristics  of  the  subjects  grouped  according  to  their  responsiveness  to  histamine  and  methacholine
linear  interpolation  of  the  log-dose-response  curve.  A  positive 
test  response  was  defined  as  PC20  <16  mg/mL.  Since  the  actual 
PC20  values  were  unobtainable  for  the  subjects  with  a  negative 
test  response,  the  bronchial  reactivity  index  (BRindex),  as 
another  index  of  AHR,  was  calculated  using  the  following 
equation:  log10  (10  +  the  maximal  %  fall  in  FEV1/log10  (the  dose 
in  mg/dL  of  the  stimulus  required  to  produce  it))
13).
Statistical  analysis
The  variables  were  summarized  as  the  mean±SEM.  All 
calculations  of  IgE  and  PC20  were  performed  after  log 
transformation.  Student's  t-test,  one  way  analysis  of  variance 
(ANOVA),  and  Chi-Square  tests  were  used  to  determine  the 
significance  of  inter-group  differences.  The  paired  Student's 
t-test  was  used  for  intra-group  comparisons.  Associations 
between  variables  were  examined  using  Pearson's  correlation 
coefficient.  A  value  of  p<0.05  was  considered  statistically 
significant.
RESULTS
The  clinical  characteristics  of  the  subjects  are  presented  in 
Table  1.  The  age,  gender,  height  and  baseline  FEV1  values  did 
not  differ  significantly  among  the  groups.  However,  the 
histamine  PC20  and  atopy  markers,  except  the  blood  eosinophil 
counts,  i.e.,  the  serum  total  IgE  levels,  the  atopy  score  and 
house  dust  mite  score,  were  significantly  different  among  the 
groups.  The  sole  positive  group  had  a  mild  AHR  to  histamine 
(PC20:  2～16  mg/mL)  in  83.3%  of  the  subjects  as  compared  to 
the  both  positive  group  that  had  a  mild  AHR  to  histamine  in 
45.6%  of  the  subjects  (p<0.001).
The  BRindex  and  maximal  %  fall  in  FEV1  in  response  to 
histamine  were  significantly  related  to  the  responses  to 
methacholine  (BRindex:  r=0.609,  maximal  FEV1  fall:  r=0.439;  all 
p<0.001)  (Figure  1,  Table  2).  However,  many  values  were 
distributed  in  the  upper  areas  of  the  lines  of  identity;  in  other 
words,  the  histamine-BRindex  and  FEV1  fall  were  higher  in  113 
(67.3%)  and  109  (64.9%)  subjects,  respectively,  and  lower  only 
in  53  (31.5%)  and  50  (29.8%)  subjects,  respectively,  than  the 
methacholine-BRindex  and  FEV1  fall,  respectively.  The  BRindex 
and  FEV1  fall  of  the  response  to  histamine  were  significantly 
higher  than  those  to  methacholine  (1.24±0.01  vs.  1.18±0.01 
and  20.6±0.9  vs.  15.5±0.8%,  respectively,  all  p<0.001).
Thirty-eight  individuals  with  a  negative  methacholine  test 
response  showed  a  positive  response  to  histamine,  whereas 
only  four  persons  with  a  negative  histamine  test  response 
showed  a  positive  response  to  methacholine.  The  BRindex  of 
the  response  to  histamine  was  significantly  higher  than  that  to 
methacholine  in  the  both  negative  group  (1.12±0.01  vs.  1.09±
0.01,  p<0.01)  and  the  sole  positive  group  (1.29±0.02  vs.  1.14±
0.01,  p<0.001),  while  there  was  no  significant  difference  in  the 
both  positive  group  (1.37±0.02  vs.  1.36±0.02,  p>0.05)  (Figure 
2).  Similarly,  the  maximal  %  fall  in  the  FEV1  for  the  response  to 
histamine  was  significantly  higher  than  that  to  methacholine  in 
the  both  negative  group  (10.8±0.8  vs.  8.3±0.8%,    p<0.01)  and 
the  sole  positive  group  (27.4±1.8  vs.  12.7±1.0%,  p<0.001), 
while  there  was  no  significant  difference  in  the  both  positive 
group  (27.3±1.0  vs.  26.3±1.1%,  p>0.05).  In  addition,  the 
BRindex  and  FEV1  fall  for  the  response  to  histamine  were 
significantly  higher  than  those  to  methacholine  in  the  subjects 
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Histamine   Methacholine   H/M
BRindex  BRindex          FEV1  fall
† BRindex        FEV1  fall
† 
Methacholine 
    BRindex 0.609
***  0.434
***     -
    FEV1  fall
† 0.583
***  0.439
*** 0.935
***       -
Blood  eosinophils 0.177
* 0.132 0.282
***  0.234
** -0.122 
Serum  total  IgE 0.304
***  0.253
*** 0.331
***  0.308
***  -0.053
Atopy  score 0.284
***  0.245
** 0.368
***  0.394
*** -0.108
House  dust  mites  score 0.257
***  0.214
** 0.336
***  0.350
*** -0.106 
BRindex:  bronchial  reactivity  index; 
†:  maximal  %  fall  in  forced  expiratory  volume  in  one  second  (FEV1)  after  histamine  or 
methacholine  bronchoprovocation;  H/M:  histamine/methacholine. 
*p<0.05, 
**p<0.01,  and 
***p<0.001. 
Table  2.  Relationship  among  the  variables 
Figure 1. Relationships of the bronchial reactivity index (BRindex), which was calculated using a formula: log10 
(10 + the maximal % fall in FEV1/log10 (the dose in mg/dL of the stimulus required to produce it)), and maximal 
% fall in the forced expiratory volume in one second (FEV1) after a bronchial challenge between histamine and 
methacholine.  The  dashed  line  is  the  line  of  identity.
26.8±1.1  vs.  17.5±1.3%,  all  p<0.001).
Both  histamine  and  methacholine  responsiveness  were 
significantly  related  to  the  blood  eosinophil  counts,  the  serum 
total  IgE  levels,  the  atopy  score  and  the  skin  responsiveness  to 
the  house  dust  mite  extracts  (Table  2).  However,  the  histamine- 
/methacholine-  BRindex  ratio  was  not  significantly  related  to  the 
atopy  markers.  Since  the  airway  responsiveness  to  histamine 
was  significantly  higher  than  that  to  methacholine  in  the  both 
negative  group  and  the  sole  positive  group,  but  not  in  the  both 
positive  group,  the  measurements  of  the  atopic  markers  were 
compared  between  the  histamine-sensitive  and  methacholine- 
sensitive  groups  as  classified  according  to  the  histamine- 
BRindex/methacholine-BRindex  ratio  in  the  both  negative  group 
and  the  sole  positive  group  (Table  3).  There  was  no  significant 
difference  between  the  groups.  In  addition,  the  histamine- 
BRindex/methacholine-BRindex  ratio  in  the  atopics  (n=55)  was 
not  significantly  different  from  that  in  the  non-atopics  (n=45) 
whose  atopy  scores  were  zero  (1.07±0.02  in  the  atopics  vs. 
1.08±0.02  in  the  non-atopics,  p=0.622).  The  subjects  with  mild 
histamine  AHR  also  showed  a  similar  result  [1.07±0.02  in  the 
atopics  (n=32)  vs.  1.09±0.03  in  the  non-atopics  (n=20), 
p=0.451]. 
The  histamine-BRindex/methacholine-BRindex  ratio  was 
significant  higher  in  the  subjects  with  histamine-AHR  or 
methacholine-AHR  than  in  those  subjects  without  it,  regardless 
of  atopy  (Figure  3).  Among  the  subjects  without  AHR,  the  ratio 
in  the  atopics  was  not  higher  than  that  in  the  others;  the 
subjects  with  AHR  also  showed  a  similar  result.  Many  of  the 
subjects  complained  of  side  effects  following  high  doses  of 
inhaled  histamine.Figure  3.  Histamine  (H)/methacholine  (M)-  bronchial  reactivity  index  (BRindex)  ratios  in  the  study  groups.
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Figure  2. Comparisons  of  the  bronchial  reactivity  index  (BRindex)  and  maximal  %  fall  in  the  forced  expiratory 
volume  in  one  second  (FEV1)  after  a  bronchial  challenge  between  histamine  and  methacholine  in  the  subjects 
with  negative  responses  to  both,  a  positive  response  to  one,  or  positive  responses  to  both  histamine  and 
methacholine  tests. Inseon  S.  Choi,  M.D.,  Greater  reactivity  to  histamine  than  to  methacholine  in  patients  with  mild  AHR 169
  Histamine Methacholine
Sensitive Sensitive 
Age  (years) 26.5±0.6   26.9±1.2
Gender  (M/F) 57/23 17/12
Height  (cm) 170.5±0.9 168.2±1.5
Blood  eosinophils  >  400/μL4   (5.0%) 5  (17.2%)
Serum  IgE  >  100  IU/mL 34  (42.5%) 15  (51.7%)
Atopy 38  (48.1%)   17  (58.6%)
House  dust  mites  SPT
†  (+) 34  (43.0%)   16  (55.2%)
FEV1  (%  predicted) 91.5±1.4 88.8±4.0
BRindex,  bronchial  reactivity  index;  FEV1,  forced  expiratory 
volume  in  one  second
†Skin  prick  test. 
Table  3.  Clinical  characteristics  of  the  histamine-sensitive  or 
methacholine-sensitive  subjects  as  classified  according  to  the 
histamine-BRindex/methacholine‐BRindex  ratio  >  or  <  1  for  the 
subjects with both negative test responses or either one positive test 
response  to  histamine  and  methacholine 
DISCUSSION
In  this  study,  the  histamine-AHR  was  significantly  related  to, 
but  significantly  greater  than  the  methacholine-AHR  in  the  both 
negative  group  and  the  sole  positive  group,  whereas  it  did  not 
differ  in  the  both  positive  group.  Juniper  et  al.
7)  investigated 
patients  with  asthma  and  found  that  the  histamine-AHR  was 
comparable  to  the  methacholine-AHR,  which  is  consistent  with 
our  results  of  the  both  positive  group.  However,  the  greater 
AHR  to  histamine  versus  methacholine  found  in  the  subjects 
with  mild  histamine  AHR  suggests  that  further  work  is  necessary 
for  correctly  interpreting  the  histamine-AHR  test  results  of  these 
groups.  Woolcock  et  al.
14)  also  reported  greater  sensitivity  to 
histamine  versus  methacholine  in  COPD  patients,  whereas  there 
was  no  difference  in  asthma  patients.  Cockcroft
15)  suggested  a 
higher  sensitivity  to  histamine  versus  methacholine  even  in 
asthma  patients.  It  seems  unlikely  that  the  differences  in 
sensitivity  in  our  study  resulted  from  any  difference  in  the 
chemical  stability  of  the  histamine  and  methacholine  solutions 
because  the  solutions  were  prepared  fresh  on  the  morning  of 
each  challenge  day.
In  addition,  this  study  showed  that  AHR  was  related  to  atopy. 
It  has  been  shown  that  the  methacholine-AHR  is  significantly 
related  to  eosinophilia
16),  the  total  IgE  level
17)  and  the  skin  test 
reactivity  to  allergens
18)  in  asthma  patients,  which  is  consistent 
with  our  results.  Then,  because  histamine  is  the  typical  mediator 
of  the  atopic  allergic  reaction  and  the  number  of  histamine 
receptors  is  increased  by  leukotrienes
6),  it  can  be  speculated 
that  atopic  individuals  may  be  specifically  sensitive  to  histamine. 
Not  only  the  animal  studies  by  Antonissen  et  al.
4,  5)  but  also  the 
in  vitro  studies  using  human  bronchial  tissues
19,  20)  have  shown 
that  exposure  to  allergen  or  an  allergic  mediator  increases  the 
response  to  histamine,  but  not  the  response  to  cholinergic 
agents.  Moreover,  Spector  and  Farr
21)  reported  that  patients  with 
asthma  were  more  sensitive  to  histamine  than  to  methacholine, 
and  atopic  asthmatics  could  not  tolerate  high  concentrations  of 
histamine.  Cockcroft  et  al.
22)  found  that  the  allergen-induced 
increase  in  reactivity  to  histamine  tended  to  be  greater  than  that 
to  methacholine,  and  it  tended  to  persist  longer. 
However,  for  the  patients  with  positive  responses  to  both 
histamine  and  methacholine  in  this  study,  their  histamine-AHR 
was  not  significantly  different  from  their  methacholine-AHR. 
Nonspecific  AHR  in  asthma  occurs  via  a  variety  of  mechanisms, 
including  genetic  linkage,  airway  inflammation,  smooth  muscle 
alteration  and  so  on.  Therefore,  even  if  the  histamine-specific 
hypersensitivity  in  atopics  would  contribute  to  the  overall  AHR,  it 
may  be  trivial  in  full-blown  asthma,  resulting  in  minimal 
difference  between  the  histamine-AHR  and  the  methacholine- 
AHR.  Alternatively,  due  to  the  airway  obstruction  in  asthma,  the 
inhaled  histamine  may  not  readily  reach  its  receptors,  which  are 
primarily  localized  in  small  airways
23),  and  this  is  unlike  the 
methacholine  receptors  that  are  predominately  localized  in  the 
central  airways
24),
  and  so  this  obscures  the  atopy-related 
histamine-specific  AHR.
Even  in  the  subjects  with  mild  histamine  AHR  in  this  study, 
atopy  was  not  associated  with  an  increased  reactivity  to 
histamine  over  methacholine.  This  discrepancy  between  our 
study  and  the  previous  studies
4, 5, 19-22)  may  be  related  to  the 
difference  in  disease  activity  between  them.  Most  of  the 
subjects  in  this  study  had  no  symptoms  of  atopic  diseases  on 
the  study  day,  and  only  about  1/10  of  the  subjects  had  blood 
eosinophilia.  The  presence  of  AHR  may  suggest  that  the 
underlying  airway  disease  is  somewhat  active,  for  which  the 
leukotrienes  that  increase  histamine  receptor  numbers  are 
working  without  regard  to  atopy.  Moreover,  chronic  exposure  to 
histamine  in  active  allergic  diseases  may  decrease  the  response 
to  histamine  through  the  mechanism  of  tachyphylaxis
25). 
Longitudinal  studies  are  needed  to  examine  whether  histamine 
reactivity  is  predominantly  increased  during  exacerbation  of 
atopic  diseases. 
Inhaled  histamine  more  frequently  produces  side  effects  such 
as  throat  irritation,  flushing  and  headache  than  does  inhaled 
methacholine
7).  Many  of  our  subjects  complained  of  side  effects 
when  given  high  doses  of  inhaled  histamine.  Unfortunately,  we 
did  not  record  their  side  effects  in  detail  and  so  we  could  not 
determine  whether  the  atopic  individuals  had  more  side  effects 
than  the  non-atopic  individuals.  Further,  a  positive  bronchial 
challenge  test  does  not  always  mean  that  a  patient  has  asthma 
because  AHR  has  been  described  in  patients  with  allergic 
rhinitis  and  also  in  those  patients  with  airflow  limitation  caused 
by  conditions  other  than  asthma
3).  Therefore,  further  investiga-
tions  involving  taking  a  through  history  of  allergy  symptoms  and The  Korean  Journal  of  Internal  Medicine  :  Vol.  22,  No.  3,  September  2007 170
conducting  peak  expiratory  flow  monitoring  for  a  considerable 
period  of  time  are  required. 
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